Lapsed Feb 8, 2023 on the fee record · High confidence
20-year base term ends Jun 12, 2027
Third maintenance fee unpaid; grace period ended.
Held by Allergan Sales, LLC
Filed Jun 12, 2007 as application 11/811,823 · Granted Feb 8, 2011
Base term, 20 years from filing, plus 773 days of patent term adjustment (USPTO delay)
Today
Lapsed Feb 8, 2023
2007
2029
Clock starts
Jun 12, 2007
Jun 12, 2007
No longer in force
Feb 8, 2023
Feb 8, 2023
Granted
Feb 8, 2011
Feb 8, 2011
Term would have run to
Jul 24, 2029
Jul 24, 2029
base term
patent term adjustment
after the term ends
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
773
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
Its term would have run to Jul 24, 2029: its 20-year base term plus 773 days of term adjustment for prosecution delay. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 12, 2007, when this application, 11/811,823, was filed | Jun 12, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +773 days, USPTO patent term adjustment record | Jul 24, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | lapsed Feb 8, 2023 | High confidence |
| Computed term end | The steps above, in order | Feb 8, 2023 | High confidence |
This family
| US 7,884,100 | this patent Feb 2023 | Feb 2023 |
| US 8,258,142 | In force Jun 2027 | Jun 2027 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 28, 2008 Reel 20729, frame 289 | Wang, Guoquan; Rieger, Jayson M.; Thompson, Robert D. | Adenosine Therapeutics, LLC | Assignment of Assignor's Interest |
| May 2, 2008 Reel 20896, frame 198 | Beauglehole, Anthony; Schmidtmann, Frank W.; Rieger, Jayson M.; Watkins, Linda; Loram, Lisa C.; Hutchinson, Mark; Thompson, Robert D. | Adenosine Therapeutics, LLC | Assignment of Assignor's Interest |
| Nov 20, 2008 Reel 21867, frame 71 | Adenosine Therapeutics, LLC | Pgxhealth, LLC | Assignment of Assignor's Interest |
| Jan 8, 2009 Reel 22075, frame 734 | Adenosine Therapeutics, LLC | Pgxhealth, LLC | Assignment of Assignor's Interest |
| Jan 28, 2011 Reel 25709, frame 994 | Pgxhealth, LLC | Trovis Pharmaceuticals, LLC | Change of Name |
| Jan 31, 2013 Reel 29728, frame 400 | Trovis Pharmaceuticals LLC | Trovis Pharmaceuticals Holdings, Inc. | Merger |
| Jan 31, 2013 Reel 29728, frame 445 | Trovis Pharmaceuticals Holdings, Inc. | Clinical Data, Inc. | Merger |
| Feb 1, 2013 Reel 29737, frame 569 | Forest Laboratories Holdings Limited | Dogwood Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Feb 1, 2013 Reel 29737, frame 389 | Clinical Data, Inc. | Dogwood Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Feb 1, 2013 Reel 29737, frame 498 | Dogwood Pharmaceuticals, Inc. | Forest Laboratories Holdings Limited | Assignment of Assignor's Interest |
| Mar 19, 2013 Reel 30045, frame 899 | Forest Laboratories Holdings Limited | Dogwood Pharmaceuticals, Inc. | Corrective Assignment to Correct the Execution Date of the Previously Recorded Assignment from December 31, 2011 to March 15, 2013 Previously Recorded on Reel 029737 Frame 0569. Assignor(S) Hereby Confirms the Execution Date of the Original Assignment Dated on December 31, 2011 Was Incorrect. |
| Jun 26, 2018 Reel 46208, frame 691 | Dogwood Pharmaceuticals, Inc. | Allergan Sales, LLC | Merger |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 773 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
14
later US patents cite this one
That is above the median of utility patents granted in 2011 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.